Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!
SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
chunjuan
Lv6
2014 积分
2023-06-06 加入
最近求助
最近应助
互助留言
Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity
7天前
已完结
Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity
12天前
已关闭
p53 at the crossroads of tumor immunity
6个月前
已完结
Antitumor Effects of β-Elemene Through Inducing Autophagy-Mediated Apoptosis in Ewing Sarcoma Family Tumor Cells
1年前
已完结
Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
1年前
已完结
Design and Synthesis of New Triazole‐Benzimidazole Derivatives as Potential PRMT5 Inhibitors
5天前
已采纳
TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation
5天前
已采纳
Contact lens-induced conjunctival hyperaemia
5天前
已采纳
Hinge axis determination of the mandible : an investigation of the accuracy of mandibular hinge axis determination by the kinematic method as compared with substitutive approximations
6天前
已采纳
Transcriptome Profiling of Tiller Buds Provides New Insights into PhyB Regulation of Tillering and Indeterminate Growth in Sorghum1
6天前
已采纳
KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma
6天前
已采纳
Controlled oxygen doping in highly dispersed Ni-loaded g-C3N4 nanotubes for efficient photocatalytic H2O2 production
6天前
已采纳
Immunogenicity and safety of booster CYD-TDV dengue vaccine after alternative primary vaccination schedules in healthy individuals aged 9–50 years: a randomised, controlled, phase 2, non-inferiority study
6天前
已采纳
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
6天前
已采纳
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
6天前
已采纳
这其实只是一个摘要
6天前
貌似就是一篇摘要
6天前
补充材料超过50M,无法上传
6天前
补充材料就是7个figure和一个table,legend也没有的。
6天前
这篇文章本来就是一个letter to editor 的文章形式
7天前
上传错了
7天前
感谢
1年前
速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论